Payment tech automates reimbursements to clinical trial sites

By Melissa Fassbender contact

- Last updated on GMT

Medidata Payments allows CROs to calculate reimbursement to investigative sites in real time. (Image: iStock/Imilian)
Medidata Payments allows CROs to calculate reimbursement to investigative sites in real time. (Image: iStock/Imilian)

Related tags: Clinical trial

The end-to-end reimbursement tool from Medidata uses clinical trial data to calculate costs and make payments to investigative sites in real time, all in the cloud.

Traditionally, clinical trial work payment​ has been challenged by slow reimbursement and calculation errors. According to the Clinical Trials Transformation Initiative​ (CTTI), payment delays result in high turnover rates among clinical investigators, with 40% of sites dropping out of FDA-regulated clinical trials.

As clinical trial protocols and budgets become increasingly complex, payments to clinical research sites have become more difficult. In addition, clinical trials are conducted globally, which means sponsors face challenges with different currencies, taxes and multiple banking regulations​,” April Mulroney, Medidata's Managing Director of Payments, told

Today, nearly 80% of all clinical trial payments are processed using a combination of manual, Excel-based processes, and single, disparate systems.

As a result, payments to clinical trial sites are often late and inaccurate. This causes significant financial strain on sites, which rely on timely reimbursement for the efforts and expenses incurred while participating in clinical trials​,” added Mulroney, who explained added that such delays and inaccuracies are one of the most significant pain points for sites.

(Image: Medidata)
(Image: Medidata)

As one solution to these challenges, Medidata​ has launched Medidata Payments​ – a new component of the company’s Medidata Clinical Cloud​.

The addition will allow clinical trial sponsors and contract research organizations (CROs) to calculate reimbursements to investigative sites in real time and make automatic payments.

The tool specifically identifies and calculates withholding tax, captures indirect tax and performs global disbursement.

Medidata Payments is an end-to-end SaaS technology that allows sponsors and CROs to calculate and disburse payments to clinical sites for the work they do on a clinical trial​,” explained Mulroney. “The core capabilities of Medidata Payments include payment calculation, disbursement and EDC and ERP integration​.”

It also features various payment calculation capabilities including pre-payments, holdbacks, split payments among different payees, payments in multiple currencies and accruals, and more.

Alistair Macdonald, president and chief operating officer, INC Research, described Medidata’s comprehensive payments solution as “an exciting addition to their platform​.”

Related news

Show more

Related products

show more

Local Lab Data Management

Local Lab Data Management

Q2 Solutions | 01-Jul-2020 | Technical / White Paper

When a clinical trial requires local or point-of-care laboratory testing, managing the resulting data can be a significant burden to both the sponsor and...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us


View more